Company intelligence / Profile preview
Purdue Pharma
Stamford, Connecticut, United Statespurduepharma.com ↗
- Ownership
- Private
- Employees
- ~1700
- Development stage
- Commercial
01
Overview
Purdue Pharma was a major pharmaceutical company known for developing and marketing OxyContin, a time-release opioid pain medication. The company faced numerous lawsuits for its role in the opioid epidemic, with allegations of misleading marketing practices regarding the addiction risks of OxyContin. In 2007, an affiliate pleaded guilty to federal charges of misbranding OxyContin as less addictive than it actually was. The company filed for bankruptcy in 2019 amid ongoing litigation.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculesopioid medications
- Industry
- Pharma
02
Drug pipeline
11 assets10 more assets in the full pipeline.
Beyond the preview
Go deeper on Purdue Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Purdue Pharma.